NIH-funded research R01 grant

Sex differences in liver cells and fatty liver disease

Official title: Characterizing zonated hepatocyte sexual dimorphism and its role in fatty liver disease

Funded at University of California, San Francisco · NIH-11257684 · Data updated 2026-11-12

This project looks at how male and female livers differ at the cell level and how those differences relate to fatty liver disease in adults.

More Fatty Liver research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2028
Funding year2026
Award (this year)$485,750
NIH project number5R01DK131227-04
Project IDNIH-11257684 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and over with or at risk for non-alcoholic fatty liver disease, and adults who can provide liver tissue samples, would be most relevant for participation.

Less likely to help

Children under 21 and people without liver disease risk factors or those seeking an immediate treatment are unlikely to directly benefit from this basic science-focused project.

What this research studies

Scientists will map which genes are active in liver cells across the liver's zones and compare those patterns between men and women. They will use human liver tissue, molecular profiling, and laboratory models to see how systemic signals (like hormones) and local signals in the liver create sex-specific patterns. The team will link these zonated, sex-specific patterns to changes seen in non-alcoholic fatty liver disease and in liver injury models. Results are intended to show which cell types and lobule locations drive sex differences in disease risk and outcomes.

Why it matters

Potential benefit: If successful, this work could help develop sex-tailored approaches to prevent, diagnose, or treat non-alcoholic fatty liver disease.

How similar studies have gone: Previous research has documented sex differences in the liver and zonation separately and early data suggest zonated sex differences exist, but applying zonation to NAFLD is a relatively new approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Wang, Bruce Mao Zheng — University of California, San Francisco
  • Study coordinator: Wang, Bruce Mao Zheng

Related research

Other NIH-funded projects on the same topics.

  • Role of fat droplets in liver fat and inflammatory signals in NAFLD

    A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11623263

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

  • How the TET1 gene affects non-alcoholic fatty liver disease

    Researchers are looking at whether changes in the TET1 gene and DNA 'tagging' (methylation) play a role in adult non-alcoholic fatty liver disease.

    NIH research State University New York Stony Brook · Stony Brook, United States · NIH-11447065

  • Hepatocellular Genetic Clues for Fatty Liver in Hispanic Adults

    A large NIH grant helps researchers study why fatty liver develops in Hispanic adults and how genetics interact with lifestyle to affect risk.

    NIH research University of Texas Rio Grande Valley · Edinburg, United States · NIH-11421441

  • Toxic fats, vitamin B12 loss, and AHR may drive fatty liver disease

    This grant looks at how certain environmental chemicals may trigger liver damage linked to fatty liver disease and how a vitamin found in the blood could be affected.

    NIH research Michigan State University · East Lansing, United States · NIH-11398883

  • Glutamine and T cells in fatty liver disease

    A study explores how liver glutamine levels affect inflammatory CD4+ T cells in fatty liver disease to find potential new ways to reduce liver inflammation.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11388863

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.